Reyon Pharmaceutical Co. Ltd. logo

Reyon Pharmaceutical Co. Ltd. (102460)

Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM
₩
9,910. 00
-50
-0.502%
₩
221.93B Market Cap
- P/E Ratio
600% Div Yield
25,823 Volume
- Eps
₩ 9,960
Previous Close
Add Transaction
Day Range
9,710 9,960
Year Range
9,100 13,200
Want to track 102460 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Reyon Pharmaceutical Co. Ltd. (102460) Statistics

Valuation metrics

Market Cap 221.93B
Enterprise value 398.38B
Trailing P/E (ttm) -5.5
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 1.32
Price/Book (mrq) 0.97
Enterprise Value/Revenue 2.78
Enterprise Value/EBITDA -25.84

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 30.42K
Average volume (90 days) 37.56K

Price summary

52-Week low 9,100
52-Week high 13,200
Beta -
50-Day moving average 10,033.75
200-Day moving average 10,270.75

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 29 Dec 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.24%
Operating margin -0.21%

Operational effectiveness

Return on assets -0.08%
Return on equity -0.16%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 7,817.18
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1,877.59
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 383.65
Total debt (mrq) -
Total Debt/Equity (mrq) 1.11
Current ratio (mrq) 0.5%
Book value per share (mrq) 10,624.82

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -